368 related articles for article (PubMed ID: 27292718)
1. [A multifocal form of cutaneous leishmaniasis caused by Leishmania infantum in an immunocompetent child treated with a short course of liposomal amphotericin B].
Taquin H; Chiaverini C; Marty P; Lacour JP
Ann Dermatol Venereol; 2016 Oct; 143(10):622-624. PubMed ID: 27292718
[TBL] [Abstract][Full Text] [Related]
2. Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B.
Paradisi A; Capizzi R; Zampetti A; Proietti I; De Simone C; Feliciani C; Amerio PL
J Infect; 2005 Dec; 51(5):e261-4. PubMed ID: 15936088
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous leishmaniasis caused by Leishmania infantum in Southern Israel.
Ben-Shimol S; Sagi O; Horev A; Avni YS; Ziv M; Riesenberg K
Acta Parasitol; 2016 Dec; 61(4):855-858. PubMed ID: 27787222
[TBL] [Abstract][Full Text] [Related]
4. Old world Leishmania infantum cutaneous leishmaniasis unresponsive to liposomal amphotericin B treated with topical imiquimod.
Hervás JA; Martín-Santiago A; Hervás D; Rojo E; Mena A; Rocamora V; Dueñas J
Pediatr Infect Dis J; 2012 Jan; 31(1):97-100. PubMed ID: 21829140
[TBL] [Abstract][Full Text] [Related]
5. Post-kala-azar dermal leishmaniasis caused by Leishmania infantum in an immunocompetent patient.
Sánchez-Albisua B; Polimón I; Pérez-Tato B; Marinero S; Fernández-López P
Int J Dermatol; 2013 Jul; 52(7):897-9. PubMed ID: 23675968
[No Abstract] [Full Text] [Related]
6. Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.
Guery R; Henry B; Martin-Blondel G; Rouzaud C; Cordoliani F; Harms G; Gangneux JP; Foulet F; Bourrat E; Baccard M; Morizot G; Consigny PH; Berry A; Blum J; Lortholary O; Buffet P;
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006094. PubMed ID: 29155816
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases.
del Rosal T; Artigao FB; Miguel MJ; de Lucas R; del Castillo F
J Trop Pediatr; 2010 Apr; 56(2):122-4. PubMed ID: 19656844
[TBL] [Abstract][Full Text] [Related]
8. Leishmaniasis due to L. infantum presenting as macrocheilitis and responding to liposomal amphotericin B.
Rongioletti F; Cannata GE; Parodi A
Eur J Dermatol; 2009; 19(3):281-2. PubMed ID: 19286487
[No Abstract] [Full Text] [Related]
9. [Cutaneous leishmaniasis treated with ambisome (liposomal amphotericin B)].
Ben-Shimol S; Sagi O; Schwartz E; Greenberg D
Harefuah; 2012 Aug; 151(8):458-60, 498. PubMed ID: 23350289
[TBL] [Abstract][Full Text] [Related]
10. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis.
Brown M; Noursadeghi M; Boyle J; Davidson RN
Br J Dermatol; 2005 Jul; 153(1):203-5. PubMed ID: 16029352
[TBL] [Abstract][Full Text] [Related]
11. [Liposomal amphotericin B treatment of cutaneous leishmaniasis caused by L. braziliensis: an imported case report].
Navarrete-Dechent C; Cevallos C; Jercic MI; Saldias-Fuentes C; González S; Labarca J
Rev Chilena Infectol; 2018; 35(5):612-616. PubMed ID: 30725012
[TBL] [Abstract][Full Text] [Related]
12. A case report of cutaneous leishmaniasis: a misleading clinical presentation.
Vanlier C; Marot L; Laranaga E; D'abadie P; Yombi JC; Yildiz H; Baeck M
Infection; 2021 Feb; 49(1):177-180. PubMed ID: 32876896
[TBL] [Abstract][Full Text] [Related]
13. Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.
Solomon M; Pavlotsky F; Leshem E; Ephros M; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):973-7. PubMed ID: 21129042
[TBL] [Abstract][Full Text] [Related]
14. A case of imported Leishmania infantum cutaneous leishmaniasis; an unusual presentation occurring 19 years after travel.
Crowe A; Slavin J; Stark D; Aboltins C
BMC Infect Dis; 2014 Nov; 14():597. PubMed ID: 25428722
[TBL] [Abstract][Full Text] [Related]
15. [Multifocal cutaneous leishmaniasis due to Leishmania infantum under adalimumab therapy].
Schneider P; Bouaziz JD; Foulet F; Duong TA; Allanore LV; Bagot M
Ann Dermatol Venereol; 2009 Nov; 136(11):815-6. PubMed ID: 19917436
[No Abstract] [Full Text] [Related]
16. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
[TBL] [Abstract][Full Text] [Related]
17. Pediatric Visceral Leishmaniasis Caused by Leishmania infantum in Northern Cyprus.
Sayili A; Ozkan AT; Schallig HD
Am J Trop Med Hyg; 2016 Dec; 95(6):1386-1388. PubMed ID: 27698271
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy.
Darcis G; Van der Auwera G; Giot JB; Hayette MP; Tassin F; Arrese Estrada J; Cnops L; Moutschen M; de Leval L; Leonard P
BMC Infect Dis; 2017 Jul; 17(1):478. PubMed ID: 28687071
[TBL] [Abstract][Full Text] [Related]
19. Failure of Liposomal-amphotericin B Treatment for New World Cutaneous Leishmaniasis due to Leishmania braziliensis.
Kosaka A; Sakamoto N; Hikone M; Imai K; Ota M; Washino T; Maeda T; Iwabuchi S
Intern Med; 2020; 59(9):1227-1230. PubMed ID: 32378656
[TBL] [Abstract][Full Text] [Related]
20. [Chronic facial ulceration in France and potential involvement of Leishmania infantum cutaneous leishmaniasis].
Lenvers P; Marty P; Peyron F
Ann Dermatol Venereol; 2013 Nov; 140(11):704-7. PubMed ID: 24206806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
